Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.Explore and learn more about Conference Series : World's leading Event Organizer
As per available reports about 2 relevant journals, 21 Conferences, 4 workshops are presently dedicated exclusively to cancer genetics and about 2,070 articles are being published on cancer genetics.
Chromosomal changes are the main features of cancer which is mainly called as alteration in the genes, typically the alteration in the genes are majorly divided in three types Oncogenes,tumor suppressor genes and the genes that preserve the integrity of the genome. Cancer is a multistep process and different kinds of alteration in the genes causes’ full blown cancer.
OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.
Scope and Importance:
Pan-genomic analyses of genetic and epigenetic alterations and gene expression profiles are providing important new insights into the pathogenesis and molecular classification of cancers. Interestingly, genomic studies of adrenal cancers have also identified subtypes of malignant tumors, which demonstrate distinct patterns of molecular alterations and are associated with different clinical outcomes. These discoveries have created the opportunity for classifying adrenocortical tumours on the basis of molecular analyses. Following these genomic studies, efforts to develop new molecular tools that improve diagnosis and prognostication of patients with adrenocortical tumours have also been made. This Review describes the progress that has been made towards classification of adrenocortical tumours to date based on key genomic approaches. In addition, the potential for the development and use of various molecular tools to personalize the management of patients with adrenocortical tumours is discussed.
The genomics era has yielded great advances in the understanding of cancer biology. At the same time, the immense complexity of the cancer genome has been revealed, as well as a striking heterogeneity at the whole-genome (or omics) level that exists between even histological similar tumors
This cancer genetics symposium will focus on how current practices are determined and how practice will evolve over the coming years. It has been developed to help busy clinicians recognise and treat families with an inherited predisposition to cancer.
Market Analysis:
The global oncology drugs market is expected to reach at $111.9 billion by 2020. Patent expiration of key cancer drugs such as Herceptin, Erbitux, Rituxan and Avastin, is expected to boost the growth of cancer biosimilars market by 2020. Going further, the biological therapies are expected to dominate the market by 2020, due to their high efficacy, target specific action and less toxicity. Blood cancer drugs market was the largest revenue generating segment in 2013 owing to the high cost of drugs (immunotherapies) used for the treatment of blood cancer.
International symposium and workshops :
ASRT Radiation Therapy Conference, October 18-20, 2015, San Antonio, Texas
Annual Radiotherapy Conference, January 30 – February 1, 2015, Thistle Bristol City Centre, The Grand Broad Street, England
ASRT Radiation Therapy Conference, October 18-20, 2015, San Antonio, Texas.
Annual Radiotherapy Conference, January 30 – February 1, 2015, Thistle Bristol City Centre, The Grand Broad Street, England
RTi3: Radiation Therapy Conference 2015, March 6 – 7, 2015, Chestnut Conference Centre, Toronto
Creating a Better Future For Cancer Patients Worldwide , Mar30- Apr 02 , 2015 , Pentagon City – Arlington, VA, United States
List of Best International Conferences :
Pancreatic and Colorectal Cancer
March 29-30, 2016 Atlanta, USA.
Blood Malignancies and Treatment
April 18-20, 2016 Dubai, UAE.
Gynecologic Oncology
May 19-21, 2016 San Antonio, USA.
Antimicrobial Agents and Chemotherapy
June 6-7, 2016 Dallas, USA.
Cancer Diagnostics Conference & Expo
June 13-15, 2016 Rome, Italy.
10th Global Oncologists Annual Meeting
July 11-13, 2016 Cologne, Germany.
11th Asia-Pacific Oncology and Oncologists Meeting
July 11-13, 2016 Kuala Lumpur, Malaysia.
Melanoma and Carcinoma
July 14-15, 2016 Brisbane, Australia.
Neuro Onclogy,
July 21-23, 2016 Brisbane, Australia.
Thyroid Cancer and Treatment
Aug 1-3, 2016 Toronto, Canada.
Oral, Mouth and Throat Cancer
Aug 18-20, 2016 Portland, Oregon.
Molecular & Cancer Biomarkers
Sept 15-17, 2016 Berlin, Germany.
Cervical Cancer
Sept 22-23, 2016 Vienna, Austria.
Radiation Oncology
Sep 26-28, 2016 Valencia, Spain.
12th Euro Global Summit on Cancer Therapy
Sept 26-28, 2016 London, UK.
13th Global Oncologists Summit and Cancer Therapy
Oct 17-19, 2016 Dubai, UAE.
Mesothelioma
Nov 3-4, 2016 Valencia, Spain.
Leukemia and Bone marrow Transplantation
Nov 10-12, 2016 Istanbul, Turkey.
14th Cancer Therapy
Dec 8-10, 2016 Baltimore, USA.
2nd Prostate Cancer and Treatment Conference
May 5-7,2016, Chicago, USA.
Relevant Society and Associations
American Society for Radiation Oncology.
American Cancer Society.
Cancer Research UK.
British Association of Urological Surgeons (BAUS).
National Cancer Institute.
Cancer society of New Zealand.
American society of clinical oncology.
Cancer Research foundation.
Cancer Research Institute.
Urological Association of Asia and Iranian.
Canadian Cancer Society.
List of Companies
IBA Proton Therapy.
Sun Nuclear.
Elekta, Inc.
RaySearch Laboratories.
Modus Medical Devices Inc.
PI (Physik Instrumente) L.P. Piezo Nanopositioning.
Accuray.
VARIAN Medical Systems Particle Therapy GmbH.
CIRS.
LifeLine Software, Inc./RadCalc.
This page will be updated regularly.
This page was last updated on November 22, 2024
